STOCK TITAN
  1. Home
  2. Sec-filings
  3. CME
  4. [8-K] CME GROUP INC. Reports Material Event

Record Q1 2026 earnings at CME Group (NASDAQ: CME) on surging volume

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

CME Group Inc. reported record first-quarter 2026 results, with revenue of $1.88 billion, up 14% from a year earlier. Operating income rose to $1.31 billion, while net income reached $1.15 billion and diluted earnings per share were $3.18.

On a non-GAAP basis, adjusted operating income was $1.37 billion, adjusted net income was $1.22 billion and adjusted diluted EPS were $3.36, each at record levels. Trading activity was exceptionally strong, with average daily volume hitting an all-time high of 36.2 million contracts, up 22%, and non-U.S. volume rising 30%. The company also returned significant capital, paying approximately $2.7 billion in dividends and repurchasing $536 million of shares in the quarter.

Positive

  • Record financial performance: Q1 2026 revenue rose 14% to $1.88 billion, with record adjusted operating income of $1.37 billion, adjusted net income of $1.22 billion, and adjusted diluted EPS of $3.36, alongside 20% growth in net income and diluted EPS.
  • Strong volume and global expansion: Average daily volume reached a record 36.2 million contracts, up 22%, with non-U.S. ADV at a record 11.4 million contracts, up 30%, indicating broad-based, international demand across all six asset classes.

Negative

  • None.

Insights

CME delivered record Q1 2026 results on surging volumes and robust non-U.S. growth.

CME Group posted record Q1 2026 revenue of $1.88 billion, up 14%, with operating income of $1.31 billion. Net income increased to $1.15 billion, and diluted EPS reached $3.18. Adjusted diluted EPS were higher at $3.36, reflecting non-GAAP add-backs.

Business momentum was driven by record average daily volume of 36.2 million contracts, up 22%, with all six asset classes setting records. Non-U.S. ADV of 11.4 million contracts grew 30%, highlighting expanding global participation. Clearing and transaction fees reached a record $1.5 billion, while market data revenue hit a record $224 million.

The company returned substantial cash to shareholders, paying about $2.7 billion in dividends and repurchasing $536 million of stock in the quarter, contributing to a decline in cash and cash equivalents to $2.39 billion as of March 31, 2026. Subsequent filings may provide more detail on sustainability of this capital return pace relative to earnings and cash generation.

Item 0.9 Item 0.9
Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Q1 2026 Revenue $1.88 billion Total revenues, up 14% vs Q1 2025
Q1 2026 Net Income $1.15 billion Quarter ended March 31, 2026
Diluted EPS $3.18 per share Q1 2026 GAAP diluted earnings per share
Adjusted Diluted EPS $3.36 per share Q1 2026 adjusted diluted EPS
Average Daily Volume 36.2 million contracts Q1 2026 ADV, up 22% vs Q1 2025
Clearing & Transaction Fees $1.54 billion Q1 2026 clearing and transaction fees revenue
Dividends Paid $2.7 billion Dividends during Q1 2026
Share Repurchases $536 million CME Group common shares repurchased in Q1 2026
non-GAAP financial measures financial
"the attached press release includes financial measures that are not in accordance with GAAP, consisting of non-GAAP revenues, expenses, operating income, net income and earnings per share"
Non-GAAP financial measures are numbers companies use to show their financial performance that exclude certain expenses or income. They help investors see how the company might perform without one-time costs or other unusual items, giving a different perspective from official reports. However, since they can be adjusted, they don’t always tell the full story and should be looked at alongside standard financial figures.
average daily volume financial
"Q1 average daily volume up 22% to a record 36.2 million contracts"
Average daily volume is the typical number of shares or contracts of a security traded each day, calculated by averaging daily trading amounts over a recent period. It matters to investors because it indicates how easy it is to buy or sell without moving the price—like traffic on a road: high volume is a busy freeway that lets many cars pass smoothly, while low volume can make large orders cause big price changes and higher costs.
performance bonds and guaranty fund contributions financial
"Performance bonds and guaranty fund contributions | 165,035.3"
Performance bonds are sums of money or a promise from a third party that a company posts to guarantee it will meet a contract or project obligation; if the company fails, the bond pays for completion or damages. Guaranty fund contributions are payments into an industry-wide pool that protects customers or counterparties if a member firm defaults. Together they matter to investors because they tie up cash, signal credit and operational risk, and can create potential future claims or protections—think of a security deposit plus a neighborhood insurance pool that both reduce but also reveal risk.
adjusted operating income financial
"On an adjusted basis, operating income was $1.4 billion"
Adjusted operating income is a company's profit from its main activities, excluding certain one-time or unusual costs and gains. It helps investors see how well the business is performing in its normal operations, without distractions from rare events or expenses. This way, they get a clearer picture of the company’s true profitability.
average rate per contract financial
"The total average rate per contract was $0.652"
forward-looking statements regulatory
"Statements in this press release that are not historical facts are forward-looking statements"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
Revenue $1.88 billion +14% vs Q1 2025
Net Income $1.15 billion
Diluted EPS $3.18 up 20% vs prior year
Adjusted Diluted EPS $3.36 up 20% vs prior year
Average Daily Volume 36.2 million contracts +22% vs Q1 2025
Understanding 8-K Material Events →
false000115637500011563752026-04-222026-04-22

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549 
_________________________________________________________
FORM 8-K
 
_________________________________________________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) April 22, 2026
 
 _________________________________________________________
CME GROUP INC.
(Exact Name of Registrant as Specified in its Charter) 
_________________________________________________________ 
Delaware 001-31553 36-4459170
(State or Other Jurisdiction
of Incorporation)		 (Commission
File No.)		 (IRS Employer
Identification No.)
 
20 South Wacker DriveChicagoIllinois 60606
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code: (312) 930-1000
N/A
(Former Name or Former Address, if Changed Since Last Report) 
______________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbolName of each exchange on which registered
Class A Common StockCMENasdaq
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) of this chapter or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition.
The information set forth under “Item 2.02. Results Of Operations and Financial Condition,” including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
Attached and incorporated herein by reference as Exhibit 99.1 is a copy of a press release of CME Group Inc. dated April 22, 2026, reporting CME Group Inc.’s financial results for the quarter ended March 31, 2026.
To supplement CME Group’s financial statements on a GAAP basis, the attached press release includes financial measures that are not in accordance with GAAP, consisting of non-GAAP revenues, expenses, operating income, net income and earnings per share. Management believes that the presentation of non-GAAP revenues, expenses, operating income, net income and earnings per share provide important supplemental information to management and investors about financial and business trends relating to CME Group Inc.’s financial condition and results of operations. Management believes that the use of these non-GAAP financial measures provide a better measure of comparability with the Company’s prior financial reports. Management acknowledges that non-GAAP adjustments may include recurring items. These non-GAAP measures should be considered as a supplement to, and not as a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP. Pursuant to the requirements of Regulation G, CME Group Inc. has included a reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures in the press release.
 
Item 9.01Financial Statements and Exhibits.
Exhibit
Number		  Description
99.1   
Press Release, dated April 22, 2026.
104 The cover page from CME Group Inc.'s Current Report on Form 8-K, formatted in Inline XBRL.



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 CME Group Inc.
 Registrant
Date: April 22, 2026 By: /s/ Lynne Fitzpatrick
 Name:

Title:		 Lynne Fitzpatrick

Senior Managing Director, President and Chief Financial Officer

Principal Financial Offer and
Duly Authorized Officer
  
































                                             Exhibit 99.1
cmeglogoa.jpg
Media contactInvestor contact
Timothy Barello, 212.299.2256Adam Minick, 312.340.8365
Laurie Bischel, 312.648.8698investors@cmegroup.com
news@cmegroup.comCME-G
cmegroup.mediaroom.com
FOR IMMEDIATE RELEASE
CME Group Inc. Reports Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q1 2026
•Record revenue of $1.9 billion, up 14%
•Net income and diluted earnings per share both up 20%
CHICAGO, April 22, 2026 - CME Group Inc. (NASDAQ: CME) today reported financial results for the first quarter of 2026.
The company reported revenue of $1.9 billion and operating income of $1.3 billion for the first quarter of 2026. Net income was $1.2 billion and diluted earnings per common share were $3.18. On an adjusted basis, operating income was $1.4 billion, net income was $1.2 billion and diluted earnings per common share were $3.36. Financial results presented on an adjusted basis for the first quarter of 2026 and 2025 exclude certain items, which are detailed in the reconciliation of non-GAAP results.1    
“In a world in which risk has become the new normal, 2026 is off to a record-breaking start as clients around the world turn to CME Group’s trusted, regulated markets to hedge across asset classes and in all trading environments," said CME Group Chairman and Chief Executive Officer Terry Duffy. "Robust demand for our products drove Q1 average daily volume up 22% to a record 36.2 million contracts, including records in all six asset classes. This exceptional market participation translated directly into record financial performance, with revenue rising 14% and adjusted net income and diluted EPS increasing 20%. Efficiencies provided to our client base also hit a new high in Q1 with over $85 billion in average daily margin savings, and we’re very pleased to further extend our FICC cross-margining agreement to end-user clients later this month. Looking ahead, innovation remains central to our growth strategy. We will continue to work closely with our clients as we expand the range of products and services we provide to help them manage risk and pursue opportunities in a rapidly evolving marketplace.”


1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of Adjusted Operating Income and Adjusted Net Income and Adjusted Diluted Earnings per Common Share charts at the end of the financial statements.
- more -





Page 2
First-quarter 2026 average daily volume (ADV) reached a quarterly all-time high of 36.2 million contracts, up 22% from first-quarter 2025. Non-U.S. ADV was a record 11.4 million contracts, up 30% compared with the same period in 2025, including the highest quarterly ADV across all regions, with APAC up 33% and EMEA up 29%.
Clearing and transaction fees revenue for first-quarter 2026 totaled a record $1.5 billion. The total average rate per contract was $0.652. Market data revenue totaled a record $224 million for first-quarter 2026.
As of March 31, 2026, the company had $2.6 billion in cash (including $200 million deposited with Fixed Income Clearing Corporation, which is included in other current assets) and $3.4 billion of debt. The company paid dividends during the first quarter of approximately $2.7 billion and repurchased $536 million in CME Group common shares.
CME Group will hold a Q&A conference call to discuss first-quarter 2026 results at 8:30 a.m. Eastern Time today. A live audio webcast of the Q&A call will be available on the Investor Relations section of CME Group's website at investor.cmegroup.com under Events & Presentations. An archived recording will be available for up to two months after the call.
As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, cryptocurrencies, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing.

CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec is a trademark of BrokerTec Americas LLC and EBS is a trademark of EBS Group LTD. The S&P 500 Index is a product of S&P Dow Jones Indices LLC (“S&P DJI”). “S&P®”, “S&P 500®”, “SPY®”, “SPX®”, US 500 and The 500 are trademarks of Standard & Poor’s Financial Services LLC; Dow Jones®, DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc. Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products. All other trademarks are the property of their respective owners.









- more -






Page 3

Statements in this press release that are not historical facts are forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Among the factors that might affect our performance are increasing competition by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of existing entities; our ability to keep pace with rapid technological developments, including our ability to complete the development, implementation and maintenance of the enhanced functionality required by our customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks; our ability to continue introducing innovative and competitive new products and services on a timely, cost-effective basis, including through our electronic trading capabilities, and derive revenues that are commensurate with our efforts and expectations, and our ability to maintain the competitiveness of our existing products and services; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to manage variable costs associated with CME Group’s transition to the Google Cloud, and minimize duplicative costs of maintaining both on-premise and Google Cloud environments during the transition; the resilience of our electronic platforms and the soundness of our business continuity and disaster recovery plans, including in the event of cyberattacks and cyberterrorism or as impacted by a failure of or disruption at one of our suppliers; our ability to maintain existing customers at substantially similar trading levels, develop strategic relationships and attract new customers; our ability to expand and globally offer our products and services; changes in regulations, including the impact of any changes in laws or government policies with respect to our products or services or our industry, such as any changes to regulations and policies that require increased financial and operational resources from us or our customers, as well as the impact of tariffs and tax policy changes, restrictions on our ability to offer CME Group products and services in specific geographies or to specific customers or limitations or changes in underlying/physical product flows across geographies; the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others; decreases in revenue from our market data as a result of decreased demand or changes to regulations in various jurisdictions; changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the impact of our tiered pricing structure; the ability of our credit and liquidity risk management practices to adequately protect us from the credit risks of clearing firms and other counterparties, and to satisfy the margin and liquidity requirements associated with the BrokerTec matched principal business; the ability of our compliance and risk management programs to effectively monitor and manage our risks, including our ability to prevent errors and misconduct and protect our infrastructure against security breaches and misappropriation of our intellectual property assets; our dependence on third-party providers and exposure to risk from third parties, including risks related to the performance, reliability and security of technology used by, or facilities provided by, our third-party providers and third-party providers that our clients and third-parties rely on; our reliance on third-party distribution partners, including independent software vendors, futures commission merchants, introducing brokers, broker-dealers, regulatory reporting and data distributors and platform operators, and other partners, for facilitating trading and for market data information, and potential impacts from changes in their business models and priorities; volatility in commodity, equity and fixed income prices, and price volatility of financial benchmarks and instruments such as interest rates, equity indices, fixed income instruments and foreign exchange rates; economic, social, political and market conditions, including new and existing geopolitical tensions or conflicts, the volatility of the capital and credit markets and the impact of economic conditions on the trading activity of our current and potential customers; our ability to accommodate increases in contract volume and market data and order transaction traffic across the entire trade cycle and the ability to implement enhancements meeting our regulatory obligations and customer needs without failure or degradation of the performance of our trading and clearing systems; our ability to execute our growth strategy and maintain our growth effectively; our ability to manage the risks, control the costs and achieve the synergies associated with our strategy for acquisitions, investments, alliances, strategic partnerships and joint ventures; variances in earnings on cash accounts and collateral that our clearing house holds; impact of CME Group pricing/fee level and structure and incentive changes; impact of aggregation services and internalization on trade flow and volumes; any negative financial impacts from changes to the terms of intellectual property and index rights; our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our business; industry, channel partner and customer consolidation and/or concentration; decreases in trading and clearing activity; the imposition of a transaction tax or user fee on





futures and options transactions and/or repeal of the 60/40 tax treatment of such transactions; increases in effective tax rates, borrowing costs, or changes in tax policy; our ability to maintain our brand and reputation; and the unfavorable resolution of material legal proceedings. For a detailed discussion and additional information concerning these and other factors that might affect our performance, see our other recent periodic filings, including our Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the Securities and Exchange Commission ("SEC") on February 26, 2026, under the caption "Risk Factors".
# # #






CME Group Inc. and Subsidiaries
Consolidated Balance Sheets
(in millions)
 
March 31, 2026December 31, 2025
ASSETS
Current Assets:
Cash and cash equivalents$2,391.2 $4,416.9 
Marketable securities124.2 125.0 
Accounts receivable, net of allowance935.5 639.2 
Other current assets (includes $6.4 and $6.5 in restricted cash)515.0 522.1 
Performance bonds and guaranty fund contributions165,035.3 159,656.1 
Total current assets169,001.2 165,359.3 
Property, net of accumulated depreciation and amortization355.4 362.7 
Intangible assets—trading products17,175.3 17,175.3 
Intangible assets—other, net2,550.8 2,610.7 
Goodwill10,506.0 10,514.7 
Other assets 2,404.8 2,401.5 
Total Assets$201,993.5 $198,424.2 
LIABILITIES AND EQUITY
Current Liabilities:
Accounts payable$75.4 $71.8 
Other current liabilities887.1 568.8 
Performance bonds and guaranty fund contributions165,035.3 159,656.1 
Total current liabilities165,997.8 160,296.7 
Long-term debt3,423.2 3,422.3 
Deferred income tax liabilities, net5,221.1 5,242.2 
Other liabilities733.2 734.8 
Total Liabilities175,375.3 169,696.0 
Total CME Group Shareholders’ Equity26,618.2 28,728.2 
Total Liabilities and Equity$201,993.5 $198,424.2 
















CME Group Inc. and Subsidiaries
Consolidated Statements of Income
(dollars in millions, except per share amounts; shares in thousands)
Quarter Ended
 March 31,
 20262025
Revenues
Clearing and transaction fees$1,542.6 $1,337.3 
Market data and information services224.1 194.5 
Other113.4 110.5 
Total Revenues1,880.1 1,642.3 
Expenses
Compensation and benefits223.0 206.7 
Technology76.6 65.7 
Professional fees and outside services28.2 28.5 
Amortization of purchased intangibles56.1 55.2 
Depreciation and amortization27.2 27.3 
Licensing and other fee agreements106.8 96.6 
Other52.5 54.3 
Total Expenses570.4 534.3 
Operating Income1,309.7 1,108.0 
Non-Operating Income (Expense)
Investment income1,389.3 892.7 
Interest and other borrowing costs(43.6)(41.7)
Equity in net earnings of unconsolidated subsidiaries102.4 88.2 
Other non-operating income (expense)(1,246.9)(802.4)
Total Non-Operating Income (Expense)201.2 136.8 
Income before Income Taxes1,510.9 1,244.8 
Income tax provision 356.6 288.6 
Net Income$1,154.3 $956.2 
Net Income Attributable to Common Shareholders of CME Group - Basic(1)
$1,168.0 $944.2 
Net Income Attributable to Common Shareholders of CME Group - Diluted(1)
$1,154.3 $944.2 
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic$3.25 $2.63 
Diluted3.18 2.62 
Weighted Average Number of Common Shares:
Basic359,318 359,613 
Diluted(2)
363,208 360,227 
1. The difference between Net Income and Net Income Attributable to Common Shareholders of CME Group - Basic and Diluted is the result of the distribution of earnings allocated to preferred shares.
2. Preferred shares of 4,584,000 were all converted on March 5, 2026 to Class A Common stock and are included in the Diluted shares for the first quarter of 2026.








CME Group Inc. and Subsidiaries
Reconciliation of Adjusted Operating Income
(dollars in millions)
Quarter Ended
 March 31,
20262025
Total Revenues$1,880.1 $1,642.3 
Adjusted Total Revenues $1,880.1 $1,642.3 
Total Expenses$570.4 $534.3 
Restructuring and severance(4.0)(1.1)
Deferred compensation(1)
0.8 2.2 
Amortization of purchased intangibles(56.1)(55.2)
Strategic transaction-related (costs) credits(0.6)— 
Real estate-related (costs) credits(0.7)— 
Foreign exchange transaction gains (losses)0.9 (2.3)
Litigation matters or settlements1.0 (3.3)
Adjusted Total Expenses $511.7 $474.6 
Operating Income $1,309.7 $1,108.0 
Adjusted Operating Income$1,368.4 $1,167.7 
1. Includes $0.8 million for a change in our non-qualified deferred compensation liability in the first quarter of 2026. This impact does not affect net income and adjusted net income, because the compensation and benefits change has an equal and offsetting change in investment income.





CME Group Inc. and Subsidiaries
Reconciliation of Adjusted Net Income and Adjusted Earnings per Common Share
(dollars in millions, except per share amounts; shares in thousands)
Quarter Ended
 March 31,
20262025
Net Income $1,154.3 $956.2 
Restructuring and severance4.0 1.1 
Amortization of purchased intangibles(1)
60.1 68.2 
Strategic transaction-related costs (credits)(2)
0.1 — 
Real estate-related costs (credits)0.7 — 
Foreign exchange transaction (gains) losses(0.9)2.3 
Unrealized and realized (gains) losses on investments22.9 6.5 
Litigation matters or settlements(1.0)3.3 
Income tax effect related to above(21.0)(16.1)
Other income tax items0.9 (1.6)
Adjusted Net Income $1,220.1 $1,019.9 
Adjusted Net Income Attributable to Common Shareholders of CME Group - Basic(3)
$1,233.2 $1,007.1 
Adjusted Net Income Attributable to Common Shareholders of CME Group - Diluted(3)
$1,220.1 $1,007.1 
Earnings per Share Attributable to Common Shareholders of CME Group:
     Basic$3.25 $2.63 
     Diluted3.18 2.62 
Adjusted Earnings per Share Attributable to Common Shareholders of CME Group:
     Basic$3.43 $2.80 
     Diluted3.36 2.80 
Weighted Average Number of Common Shares:
     Basic359,318 359,613 
     Diluted(4)
363,208 360,227 
1. Includes $2.6 million of amortization of purchased intangibles at S&P Dow Jones Indices LLC and $1.4 million of amortization of purchased intangibles at FanDuel Prediction Markets Holdings LLC in the first quarter of 2026. This is reported in Equity in net earnings of unconsolidated subsidiaries on the Consolidated Statements of Income.
2. The values shown above may differ from what is shown in the Reconciliation of Adjusted Operating Income as
that schedule does not include adjustment items or portions of items included in non-operating results.
3. The difference between Adjusted Net Income and Adjusted Net Income Attributable to Common Shareholders of CME Group - Basic and Diluted is the result of the distribution of earnings allocated to preferred shares.
4. Preferred shares of 4,584,000 were all converted on March 5, 2026 to Class A Common stock and are included in the Diluted shares for the first quarter of 2026.








CME Group Inc. and Subsidiaries
Quarterly Operating Statistics
 
1Q 20252Q 20253Q 20254Q 20251Q 2026
Trading Days61 62 64 64 61 
Quarterly Average Daily Volume (ADV)(1)
CME Group ADV (in thousands)
 
Product Line1Q 20252Q 20253Q 20254Q 20251Q 2026
Interest rates15,029 15,472 13,378 13,010 18,674 
Equity indexes7,997 7,661 6,278 7,738 8,655 
Foreign exchange1,149 1,096 834 853 1,193 
Energy2,903 3,082 2,295 2,523 3,985 
Agricultural commodities1,958 1,964 1,712 1,787 2,042 
Metals732 943 825 1,441 1,682 
Total29,768 30,217 25,322 27,353 36,231 
Venue
CME Globex27,732 28,097 23,418 25,542 33,633 
Open outcry 881 993 989 816 1,241 
Privately negotiated1,154 1,127 915 995 1,357 
Total29,768 30,217 25,322 27,353 36,231 
Quarterly Average Rate Per Contract (RPC)(1)
CME Group RPC
 
Product Line1Q 20252Q 20253Q 20254Q 20251Q 2026
Interest rates$0.476 $0.481 $0.487 $0.486 $0.457 
Equity indexes0.624 0.635 0.652 0.611 0.597 
Foreign exchange0.762 0.772 0.841 0.847 0.780 
Energy1.222 1.138 1.214 1.245 1.084 
Agricultural commodities1.376 1.435 1.423 1.427 1.344 
Metals1.588 1.456 1.505 1.295 1.153 
Average RPC$0.686 $0.690 $0.702 $0.707 $0.652 
1. ADV and RPC includes futures and options on futures only.





Source: View Original Filing on SEC EDGAR

FAQ

How did CME Group (CME) perform financially in Q1 2026?

CME Group reported strong Q1 2026 results with revenue of $1.88 billion, up 14% year over year. Net income reached $1.15 billion and diluted EPS were $3.18, reflecting robust trading activity and record performance across key revenue lines.

What were CME Group (CME) non-GAAP earnings and adjustments for Q1 2026?

On an adjusted basis, CME Group posted Q1 2026 net income of $1.22 billion and adjusted diluted EPS of $3.36. Adjustments included items such as restructuring and severance, amortization of purchased intangibles, investment gains and losses, and related income tax effects.

How did CME Group’s (CME) trading volumes trend in Q1 2026?

CME Group’s Q1 2026 average daily volume reached a record 36.2 million contracts, up 22% from Q1 2025. All six asset classes set records, and non-U.S. ADV grew 30% to 11.4 million contracts, underscoring strong global participation in its markets.

What capital returns did CME Group (CME) make to shareholders in Q1 2026?

During Q1 2026, CME Group paid approximately $2.7 billion in dividends and repurchased $536 million of common shares. These significant capital returns coincided with record profitability and contributed to a reduction in cash and cash equivalents during the quarter.

How did CME Group’s (CME) market data and clearing revenues perform in Q1 2026?

In Q1 2026, CME Group generated record clearing and transaction fees revenue of $1.54 billion and market data revenue of $224.1 million. The total average rate per contract was $0.652, reflecting the mix of products, venues, and customer types traded.

What is CME Group’s (CME) cash and debt position as of March 31, 2026?

As of March 31, 2026, CME Group held $2.39 billion in cash and cash equivalents and $3.42 billion of long-term debt. Total assets were $201.99 billion, largely reflecting performance bonds and guaranty fund contributions associated with its clearing operations.

Filing Exhibits & Attachments

4 documents

Press Releases

Other Documents